These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12452937)

  • 1. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds.
    Shaw IS; Jobson BA; Silverman D; Ford J; Hearing SD; Ball D; Johnson E; Day A; Probert CS
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2053-9. PubMed ID: 12452937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease.
    Shale MJ; Riley SA
    Aliment Pharmacol Ther; 2003 Jul; 18(2):191-8. PubMed ID: 12869079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study.
    Gifford AE; Berg AH; Lahiff C; Cheifetz AS; Horowitz G; Moss AC
    Am J Gastroenterol; 2013 Feb; 108(2):249-55. PubMed ID: 23295279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease.
    Carty E; MacEy M; Rampton DS
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1169-79. PubMed ID: 10971234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple method for the determination of 5-aminosalicylic and N-acetyl-5-aminosalicylic acid in rectal tissue biopsies.
    Hussain FN; Ajjan RA; Moustafa M; Anderson JC; Riley SA
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):257-66. PubMed ID: 9824239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.
    Allgayer H; Ahnfelt NO; Kruis W; Klotz U; Frank-Holmberg K; Söderberg HN; Paumgartner G
    Gastroenterology; 1989 Jul; 97(1):38-41. PubMed ID: 2566551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
    Edmond LM; Hopkins MJ; Magee EA; Cummings JH
    Inflamm Bowel Dis; 2003 Jan; 9(1):10-7. PubMed ID: 12656132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
    Batta AK; Tint GS; Xu G; Shefer S; Salen G
    J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection.
    Palumbo G; Carlucci G; Mazzeo P; Frieri G; Pimpo MT; Fanini D
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):175-80. PubMed ID: 8833980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies.
    Simmonds NJ; Millar AD; Blake DR; Rampton DS
    Aliment Pharmacol Ther; 1999 Mar; 13(3):363-72. PubMed ID: 10102970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonadherence in inflammatory bowel disease: results of factor analysis.
    Cervený P; Bortlík M; Kubena A; Vlcek J; Lakatos PL; Lukás M
    Inflamm Bowel Dis; 2007 Oct; 13(10):1244-9. PubMed ID: 17538983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.
    Low A; Love M; Walt R; Kane K; Eksteen B; Goh J
    World J Gastroenterol; 2010 Feb; 16(5):578-82. PubMed ID: 20128025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminosalicylic acid.
    Iida T; Onodera K; Nakase H
    Nihon Rinsho; 2017 Mar; 75(3):392-397. PubMed ID: 30566780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
    Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
    J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
    Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
    Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents.
    Present DH
    Gastroenterology; 2000 Jul; 119(1):276. PubMed ID: 10928833
    [No Abstract]   [Full Text] [Related]  

  • 20. The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.
    Støa-Birketvedt G; Florholmen J
    Aliment Pharmacol Ther; 1999 Mar; 13(3):357-61. PubMed ID: 10102969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.